Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GEn1E-1124
Clinical trial NCT04728061 · COMPLETED
Trial details
- NCT number
- NCT04728061
- Sponsor
- GEn1E Lifesciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-07
- Primary completion
- 2021-06-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.